-
1
-
-
42649123535
-
-
SEER Cancer Statistics Review, 1975-2007
-
SEER Cancer Statistics Review, 1975-2007 (2010) National Cancer Institute. http://seer.cancer.gov/csr/1975-2007/
-
(2010)
National Cancer Institute
-
-
-
2
-
-
0034680102
-
Molecular portraits of human breast tumours
-
doi: 10.1038/35021093
-
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borre-sen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752. doi: 10.1038/35021093
-
(2000)
Nature
, vol.406
, Issue.6797
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
Van De Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lonning, P.E.15
Borre-Sen-Dale, A.L.16
Brown, P.O.17
Botstein, D.18
-
3
-
-
0037478605
-
Repeated observation of breast tumor subtypes in independent gene expression data sets
-
doi:10.1073/pnas.0932692100
-
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14): 8418-8423. doi:10.1073/pnas.0932692100
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.14
, pp. 8418-8423
-
-
Sorlie, T.1
Tibshirani, R.2
Parker, J.3
Hastie, T.4
Marron, J.S.5
Nobel, A.6
Deng, S.7
Johnsen, H.8
Pesich, R.9
Geisler, S.10
Demeter, J.11
Perou, C.M.12
Lonning, P.E.13
Brown, P.O.14
Borresen-Dale, A.L.15
Botstein, D.16
-
4
-
-
1342326910
-
Relevance of breast cancer cell lines as models for breast tumours: An update
-
doi:10.1023/B:BREA.0000014042.54925.cc
-
Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83(3):249-289. doi:10.1023/B:BREA.0000014042.54925.cc
-
(2004)
Breast Cancer Res Treat
, vol.83
, Issue.3
, pp. 249-289
-
-
Lacroix, M.1
Leclercq, G.2
-
5
-
-
31044441241
-
Gene expression profiling of breast cell lines identifies potential new basal markers
-
doi: 10.1038/sj.onc.1209254
-
Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, Bertucci F (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25(15):2273-2284. doi: 10.1038/sj.onc.1209254
-
(2006)
Oncogene
, vol.25
, Issue.15
, pp. 2273-2284
-
-
Charafe-Jauffret, E.1
Ginestier, C.2
Monville, F.3
Finetti, P.4
Adélaïde, J.5
Cervera, N.6
Fekairi, S.7
Xerri, L.8
Jacquemier, J.9
Birnbaum, D.10
Bertucci, F.11
-
6
-
-
33845209913
-
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
-
doi:10.1016/j.ccr.2006. 10.008
-
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527. doi:10.1016/j.ccr.2006. 10.008
-
(2006)
Cancer Cell
, vol.10
, Issue.6
, pp. 515-527
-
-
Neve, R.M.1
Chin, K.2
Fridlyand, J.3
Yeh, J.4
Baehner, F.L.5
Fevr, T.6
Clark, L.7
Bayani, N.8
Coppe, J.P.9
Tong, F.10
Speed, T.11
Spellman, P.T.12
Devries, S.13
Lapuk, A.14
Wang, N.J.15
Kuo, W.L.16
Stilwell, J.L.17
Pinkel, D.18
Albertson, D.G.19
Waldman, F.M.20
McCormick, F.21
Dickson, R.B.22
Johnson, M.D.23
Lippman, M.24
Ethier, S.25
Gazdar, A.26
Gray, J.W.27
more..
-
7
-
-
84863720133
-
Definition of triple-negative breast cancer and relationship to basal-like molecular subtype
-
Liedtke C, Gonzalez-Angulo A-M, Pusztai L (2010) Definition of triple-negative breast cancer and relationship to basal-like molecular subtype. PPO Updates Prin Prac Oncol 24:1-6
-
(2010)
PPO Updates Prin Prac Oncol
, vol.24
, pp. 1-6
-
-
Liedtke, C.1
Gonzalez-Angulo, A.-M.2
Pusztai, L.3
-
8
-
-
77950690621
-
Adjuvant therapy of triple negative breast cancer
-
doi:10.1007/s10549-010-0736-z
-
Perez EA, Moreno-Aspitia A, Aubrey Thompson E, Andorfer CA (2010) Adjuvant therapy of triple negative breast cancer. Breast Cancer Res Treat 120(2):285-291. doi:10.1007/s10549-010-0736-z
-
(2010)
Breast Cancer Res Treat
, vol.120
, Issue.2
, pp. 285-291
-
-
Perez, E.A.1
Moreno-Aspitia, A.2
Aubrey Thompson, E.3
Andorfer, C.A.4
-
9
-
-
77956170550
-
New insights into apoptosis signaling by Apo2L/TRAIL
-
doi: 10.1038/onc.2010.221
-
Gonzalvez F, Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29(34):4752-4765. doi: 10.1038/onc.2010.221
-
(2010)
Oncogene
, vol.29
, Issue.34
, pp. 4752-4765
-
-
Gonzalvez, F.1
Ashkenazi, A.2
-
10
-
-
45749098451
-
To kill a tumor cell: The potential of proapoptotic receptor agonists
-
doi:10.1172/JCI34359
-
Ashkenazi A, Herbst RS (2008) To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118(6):1979-1990. doi:10.1172/JCI34359
-
(2008)
J Clin Invest
, vol.118
, Issue.6
, pp. 1979-1990
-
-
Ashkenazi, A.1
Herbst, R.S.2
-
11
-
-
79952336885
-
Combined modality therapy with TRAIL or agonistic death receptor antibodies
-
doi:10.4161/cbt.11. 5.14671
-
Amm HM, Oliver PG, Lee CH, Li Y, Buchsbaum DJ (2011) Combined modality therapy with TRAIL or agonistic death receptor antibodies. Cancer Biol Ther 11:431-449. doi:10.4161/cbt.11. 5.14671
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 431-449
-
-
Amm, H.M.1
Oliver, P.G.2
Lee, C.H.3
Li, Y.4
Buchsbaum, D.J.5
-
12
-
-
77949670310
-
Death receptor agonists as a targeted therapy for cancer
-
doi:10.1158/1078-0432.CCR-09-1692
-
Wiezorek J, Holland P, Graves J (2010) Death receptor agonists as a targeted therapy for cancer. Clin Cancer Res 16(6):1701-1708. doi:10.1158/1078-0432.CCR-09-1692
-
(2010)
Clin Cancer Res
, vol.16
, Issue.6
, pp. 1701-1708
-
-
Wiezorek, J.1
Holland, P.2
Graves, J.3
-
13
-
-
58149237789
-
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
-
doi:10.1007/s10549-008-9924-5
-
Rahman M, Davis SR, Pumphrey JG, Bao J, Nau MM, Meltzer PS, Lipkowitz S (2009) TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat 113:217-230. doi:10.1007/s10549- 008-9924-5
-
(2009)
Breast Cancer Res Treat
, vol.113
, pp. 217-230
-
-
Rahman, M.1
Davis, S.R.2
Pumphrey, J.G.3
Bao, J.4
Nau, M.M.5
Meltzer, P.S.6
Lipkowitz, S.7
-
14
-
-
0141679399
-
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model
-
Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF (2003) Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res 9:3731-3741
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3731-3741
-
-
Buchsbaum, D.J.1
Zhou, T.2
Grizzle, W.E.3
Oliver, P.G.4
Hammond, C.J.5
Zhang, S.6
Carpenter, M.7
Lobuglio, A.F.8
-
15
-
-
17944376030
-
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
-
doi:10.1038/91000
-
Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP, Zhou T (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7:954-960. doi:10.1038/91000
-
(2001)
Nat Med
, vol.7
, pp. 954-960
-
-
Ichikawa, K.1
Liu, W.2
Zhao, L.3
Wang, Z.4
Liu, D.5
Ohtsuka, T.6
Zhang, H.7
Mountz, J.D.8
Koopman, W.J.9
Kimberly, R.P.10
Zhou, T.11
-
16
-
-
42249113878
-
Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11
-
doi:10.1158/1078-0432.CCR-07-1392
-
Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ (2008) Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. Clin Cancer Res 14:2180-2189. doi:10.1158/1078-0432.CCR-07-1392
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2180-2189
-
-
Oliver, P.G.1
Lobuglio, A.F.2
Zinn, K.R.3
Kim, H.4
Nan, L.5
Zhou, T.6
Wang, W.7
Buchsbaum, D.J.8
-
17
-
-
0003043542
-
The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
-
Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40(Suppl):4-5
-
(1910)
J Physiol
, vol.40
, Issue.SUPPL.
, pp. 4-5
-
-
Hill, A.V.1
-
18
-
-
0018394195
-
Simultaneous modeling of pharmacokinetics and pharmacody-namics: Application to d-tubocurarine
-
Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacody-namics: application to d-tubocurarine. Clin Pharmacol Ther 25(3):358-371
-
(1979)
Clin Pharmacol Ther
, vol.25
, Issue.3
, pp. 358-371
-
-
Sheiner, L.B.1
Stanski, D.R.2
Vozeh, S.3
Miller, R.D.4
Ham, J.5
-
19
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.-C.1
Talalay, P.2
-
20
-
-
2042479407
-
Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes
-
doi: 10.1016/j.jcis.2003.12.009
-
Zhao L, Feng SS (2004) Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes. J Colloid Interface Sci 274(1):55-68. doi: 10.1016/j.jcis.2003.12.009
-
(2004)
J Colloid Interface Sci
, vol.274
, Issue.1
, pp. 55-68
-
-
Zhao, L.1
Feng, S.S.2
-
21
-
-
0037417134
-
Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway
-
doi:10.1038/sj.onc.1206290
-
Ohtsuka T, Buchsbaum D, Oliver P, Makhija S, Kimberly R, Zhou T (2003) Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22:2034-2044. doi:10.1038/sj.onc.1206290
-
(2003)
Oncogene
, vol.22
, pp. 2034-2044
-
-
Ohtsuka, T.1
Buchsbaum, D.2
Oliver, P.3
Makhija, S.4
Kimberly, R.5
Zhou, T.6
-
22
-
-
33644515676
-
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
-
doi:10.1016/j.ygyno.2005.09.053
-
Straughn JM Jr, Oliver PG, Zhou T, Wang W, Alvarez RD, Grizzle WE, Buchsbaum DJ (2006) Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model. Gynecol Oncol 101:46-54. doi:10.1016/j.ygyno.2005.09.053
-
(2006)
Gynecol Oncol
, vol.101
, pp. 46-54
-
-
Straughn, Jr.J.M.1
Oliver, P.G.2
Zhou, T.3
Wang, W.4
Alvarez, R.D.5
Grizzle, W.E.6
Buchsbaum, D.J.7
-
23
-
-
34848912648
-
Combination treatment with TRA-8 anti-death receptor-5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer
-
doi:10.1158/1078-0432.CCR-07-1075
-
DeRosier LC, Buchsbaum DJ, Oliver PG, Huang Z-Q, Sellers JC, Grizzle WE, Wang W, Zhou T, Zinn KR, Long JW, Vickers SM (2007) Combination treatment with TRA-8 anti-death receptor-5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin Cancer Res 13:5535s-5543s. doi:10.1158/1078-0432.CCR-07-1075
-
(2007)
Clin Cancer Res
, vol.13
-
-
Derosier, L.C.1
Buchsbaum, D.J.2
Oliver, P.G.3
Huang, Z.-Q.4
Sellers, J.C.5
Grizzle, W.E.6
Wang, W.7
Zhou, T.8
Zinn, K.R.9
Long, J.W.10
Vickers, S.M.11
-
24
-
-
37549019355
-
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologi-cally validated orthotopic pancreatic tumor growth
-
doi:10.1158/1535-7163.MCT-07-0299
-
DeRosier LC, Vickers SM, Zinn KR, Huang Z, Wang W, Grizzle WE, Sellers JC, Stockard CR Jr, Zhou T, Oliver PG, Arnoletti JP, LoBuglio AF, Buchsbaum DJ (2007) TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologi-cally validated orthotopic pancreatic tumor growth. Mol Cancer Ther 6:3198-3207. doi:10.1158/1535-7163.MCT-07-0299
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 3198-3207
-
-
Derosier, L.C.1
Vickers, S.M.2
Zinn, K.R.3
Huang, Z.4
Wang, W.5
Grizzle, W.E.6
Sellers, J.C.7
Stockard, Jr.C.R.8
Zhou, T.9
Oliver, P.G.10
Arnoletti, J.P.11
Lobuglio, A.F.12
Buchsbaum, D.J.13
-
25
-
-
43049152921
-
Enhancement of glioma radiation therapy and chemotherapy response with targeted antibody therapy against death receptor 5
-
doi: 10.1016/j.ijrobp.2008.02.005
-
Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ (2008) Enhancement of glioma radiation therapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int J Radiat Oncol Biol Phys 71:507-516. doi: 10.1016/j.ijrobp.2008.02.005
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 507-516
-
-
Fiveash, J.B.1
Gillespie, G.Y.2
Oliver, P.G.3
Zhou, T.4
Belenky, M.L.5
Buchsbaum, D.J.6
-
26
-
-
33749002876
-
Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function
-
doi:10.1158/0008-5472.CAN-05-4364
-
Li Y, Wang H, Wang Z, Makhija S, Buchsbaum D, LoBuglio A, Kimberly R, Zhou T (2006) Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function. Cancer Res 66:8520-8528. doi:10.1158/0008-5472.CAN-05-4364
-
(2006)
Cancer Res
, vol.66
, pp. 8520-8528
-
-
Li, Y.1
Wang, H.2
Wang, Z.3
Makhija, S.4
Buchsbaum, D.5
Lobuglio, A.6
Kimberly, R.7
Zhou, T.8
-
27
-
-
56349124589
-
Identification of an antiapoptotic protein complex at death receptors
-
doi:10.1038/cdd.2008.124
-
Sun M, Song L, Li Y, Zhou T, Jope RS (2008) Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ 15(12):1887-1900. doi:10.1038/cdd.2008.124
-
(2008)
Cell Death Differ
, vol.15
, Issue.12
, pp. 1887-1900
-
-
Sun, M.1
Song, L.2
Li, Y.3
Zhou, T.4
Jope, R.S.5
-
28
-
-
54249116378
-
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging
-
doi:10.1158/0008-5472.CAN-08-1771
-
Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR (2008) Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res 68:8369-8376. doi:10.1158/0008-5472.CAN-08-1771
-
(2008)
Cancer Res
, vol.68
, pp. 8369-8376
-
-
Kim, H.1
Morgan, D.E.2
Buchsbaum, D.J.3
Zeng, H.4
Grizzle, W.E.5
Warram, J.M.6
Stockard, C.R.7
McNally, L.R.8
Long, J.W.9
Sellers, J.C.10
Forero, A.11
Zinn, K.R.12
-
29
-
-
84863728920
-
Striking antitumor efficacy of monoclonal antibodies to DR4 and DR5 with or without chemotherapy in a human breast cancer model
-
Waikoloa, HI, 13-17 Feb 2002
-
Buchsbaum DJ, Zhou T, Oliver PG, Hammond CJ, Carpenter M, LoBuglio AF (2002) Striking antitumor efficacy of monoclonal antibodies to DR4 and DR5 with or without chemotherapy in a human breast cancer model. In: AACR special conference in cancer research apoptosis and cancer: basic mechanisms and therapeutic opportunities in the post-genomic era meeting, Waikoloa, HI, 13-17 Feb 2002
-
(2002)
AACR Special Conference in Cancer Research Apoptosis and Cancer: Basic Mechanisms and Therapeutic Opportunities in the Post-genomic Era Meeting
-
-
Buchsbaum, D.J.1
Zhou, T.2
Oliver, P.G.3
Hammond, C.J.4
Carpenter, M.5
Lobuglio, A.F.6
-
30
-
-
0032146256
-
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier
-
Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF (1998) Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58(15):3237-3242
-
(1998)
Cancer Res
, vol.58
, Issue.15
, pp. 3237-3242
-
-
Tomlinson, G.E.1
Chen, T.T.2
Stastny, V.A.3
Virmani, A.K.4
Spillman, M.A.5
Tonk, V.6
Blum, J.L.7
Schneider, N.R.8
Wistuba, I.I.9
Shay, J.W.10
Minna, J.D.11
Gazdar, A.F.12
-
31
-
-
31544474577
-
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants
-
doi:10.1158/0008-5472.CAN-05-2853
-
Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M (2006) BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66(1):41-45. doi:10.1158/0008-5472.CAN-05-2853
-
(2006)
Cancer Res
, vol.66
, Issue.1
, pp. 41-45
-
-
Elstrodt, F.1
Hollestelle, A.2
Nagel, J.H.3
Gorin, M.4
Wasielewski, M.5
Van Den Ouweland, A.6
Merajver, S.D.7
Ethier, S.P.8
Schutte, M.9
-
32
-
-
79952264098
-
New strategies in HER2-over-expressing breast cancer: Many combinations of targeted drugs available
-
doi:10.1158/1078-0432. CCR-09-1947
-
Abramson V, Arteaga CL (2011) New strategies in HER2-over-expressing breast cancer: many combinations of targeted drugs available. Clin Cancer Res 17(5):952-958. doi:10.1158/1078-0432. CCR-09-1947
-
(2011)
Clin Cancer Res
, vol.17
, Issue.5
, pp. 952-958
-
-
Abramson, V.1
Arteaga, C.L.2
-
33
-
-
77649301860
-
Phase i trial of weekly Tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)
-
doi:10.1089/cbr.2009.0673
-
Forero-Torres A, Shah J, Wood T, Posey J, Carlisle R, Copig-neaux C, Luo FR, Wojtowicz-Praga S, Percent I, Saleh M (2010) Phase I trial of weekly Tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5). Cancer Biother Radiopharm 25:13-19. doi:10.1089/cbr.2009.0673
-
(2010)
Cancer Biother Radiopharm
, vol.25
, pp. 13-19
-
-
Forero-Torres, A.1
Shah, J.2
Wood, T.3
Posey, J.4
Carlisle, R.5
Copig-Neaux, C.6
Luo, F.R.7
Wojtowicz-Praga, S.8
Percent, I.9
Saleh, M.10
|